{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:36:42Z","timestamp":1783741002378,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,7]]},"DOI":"10.7759\/cureus.85495","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T09:03:22Z","timestamp":1749287002000},"source":"Crossref","is-referenced-by-count":2,"title":["Cutaneous Adverse Effects of Hydroxychloroquine and Leflunomide in Connective Tissue Diseases: A Report of Three Cases and a Literature Review"],"prefix":"10.7759","author":[{"given":"Carina-Andreea","family":"Bazon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Porumb-Andrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Hutanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olguta","family":"Orzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daciana Elena","family":"Branisteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Disease-Modifying Antirheumatic Drugs (DMARD)","author":"Benjamin O","year":"2025","unstructured":"Benjamin O, Goyal A, Lappin SL. Disease-Modifying Antirheumatic Drugs (DMARD). StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-025-00919-x","article-title":"Safety of hydroxychloroquine: what a dermatologist should know","volume":"26","author":"Rapparini L","year":"2025","unstructured":"Rapparini L, Cedirian S, La Placa M, Piraccini BM, Raschi E, Starace M. Safety of hydroxychloroquine: what a dermatologist should know. Am J Clin Dermatol. 2025, 26:251-64. 10.1007\/s40257-025-00919-x","journal-title":"Am J Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.024","article-title":"Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review","volume":"83","author":"Sharma AN","year":"2020","unstructured":"Sharma AN, Mesinkovska NA, Paravar T. Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review. J Am Acad Dermatol. 2020, 83:563-78. 10.1016\/j.jaad.2020.04.024","journal-title":"J Am Acad Dermatol"},{"key":"ref4","unstructured":"Plaquenil - hydroxychloroquine sulfate. (2015). https.\/\/www.tga.gov.au\/sites\/default\/files\/2024-07\/FOI%205083%20Documents.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2021.09.007","article-title":"Leflunomide-induced phototoxic reaction in a woman with systemic lupus erythematosus","volume":"112","author":"Navarro-Trivi\u00f1o FJ","year":"2021","unstructured":"Navarro-Trivi\u00f1o FJ, Lucas-Collado N, Salvatierra-Ossorio J. Leflunomide-induced phototoxic reaction in a woman with systemic lupus erythematosus. Actas Dermo-Sifiliogr\u00e1ficas (English). 2021, 112:939-41. 10.1016\/j.adengl.2021.09.007","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2014.21.6.326","article-title":"Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis","volume":"21","author":"Je JH","year":"2014","unstructured":"Je JH, Lee HJ, Na YJ, et al.. Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis. J Rheum Dis. 2014, 21:326-30. 10.4078\/jrd.2014.21.6.326","journal-title":"J Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/14508.8667","article-title":"Rare occurrence of drug induced subacute cutaneous lupus erythematosus with leflunomide therapy","volume":"10","author":"Singh H","year":"2016","unstructured":"Singh H, Sukhija G, Tanwar V, Arora S, Bhutani J. Rare occurrence of drug induced subacute cutaneous lupus erythematosus with leflunomide therapy. J Clin Diagn Res. 2016, 10:OD06-7. 10.7860\/JCDR\/2016\/14508.8667","journal-title":"J Clin Diagn Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier E","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020, 16:155-66. 10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2016.05.006","article-title":"Drug-induced photosensitivity: photoallergic and phototoxic reactions","volume":"34","author":"Monteiro AF","year":"2016","unstructured":"Monteiro AF, Rato M, Martins C. Drug-induced photosensitivity: photoallergic and phototoxic reactions. Clin Dermatol. 2016, 34:571-81. 10.1016\/j.clindermatol.2016.05.006","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1740591","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies","volume":"16","author":"Lin CC","year":"2020","unstructured":"Lin CC, Chen CB, Wang CW, Hung SI, Chung WH. Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies. Expert Rev Clin Immunol. 2020, 16:373-87. 10.1080\/1744666X.2020.1740591","journal-title":"Expert Rev Clin Immunol"},{"key":"ref11","article-title":"Pharmacology, dosing, and adverse effects of leflunomide in the treatment of rheumatoid arthritis","author":"Fox RI","year":"2025","unstructured":"Fox RI, Helfgott SM. Pharmacology, dosing, and adverse effects of leflunomide in the treatment of rheumatoid arthritis. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2025."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/2324709621997282","article-title":"An uncommon presentation of DRESS syndrome secondary to leflunomide use: a case report","volume":"9","author":"Rao S","year":"2021","unstructured":"Rao S, Sunkara A, Srivastava N, Sampat P, Ramos C, Albert E. An uncommon presentation of DRESS syndrome secondary to leflunomide use: a case report. J Investig Med High Impact Case Rep. 2021, 9:2324709621997282. 10.1177\/2324709621997282","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref13","article-title":"Chloroquine and Hydroxychloroquine Toxicity","author":"Stokkermans TJ","year":"2025","unstructured":"Stokkermans TJ, Falkowitz DM, Trichonas G. Chloroquine and Hydroxychloroquine Toxicity. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/styx9u","article-title":"The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events","volume":"39","author":"Gisondi P","year":"2021","unstructured":"Gisondi P, Piaserico S, Bordin C, et al.. The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events. Clin Exp Rheumatol. 2021, 39:1099-107. 10.55563\/clinexprheumatol\/styx9u","journal-title":"Clin Exp Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv018","article-title":"Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases","volume":"70","author":"Al-Bari MA","year":"2015","unstructured":"Al-Bari MA. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015, 70:1608-21. 10.1093\/jac\/dkv018","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04868-6","article-title":"Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities","volume":"41","author":"Muller R","year":"2021","unstructured":"Muller R. Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatol Int. 2021, 41:1189-202. 10.1007\/s00296-021-04868-6","journal-title":"Rheumatol Int"},{"key":"ref17","unstructured":"Annex I. summary of product characteristics\r\n. (2025). https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/arava-epar-product-information_en.pdf."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.26725","article-title":"Severe cutaneous adverse drug reaction to leflunomide: a report of five cases","volume":"72","author":"Shastri V","year":"2006","unstructured":"Shastri V, Betkerur J, Kushalappa PA, Savita TG, Parthasarathi G. Severe cutaneous adverse drug reaction to leflunomide: a report of five cases. Indian J Dermatol Venereol Leprol. 2006, 72:286-9. 10.4103\/0378-6323.26725","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A347","article-title":"Leflunomide-associated skin ulceration","volume":"36","author":"McCoy CM","year":"2002","unstructured":"McCoy CM. Leflunomide-associated skin ulceration. Ann Pharmacother. 2002, 36:1009-11. 10.1345\/aph.1A347","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/356176-cutaneous-adverse-effects-of-hydroxychloroquine-and-leflunomide-in-connective-tissue-diseases-a-report-of-three-cases-and-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T09:03:23Z","timestamp":1749287003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/356176-cutaneous-adverse-effects-of-hydroxychloroquine-and-leflunomide-in-connective-tissue-diseases-a-report-of-three-cases-and-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.85495","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,7]]}}}